Disease-free survival analysis for donor versus no donor, by cytogenetic risk group.
| . | No. of Patients . | . | ||
|---|---|---|---|---|
| Study Group (ref), Cytogenetic Risk Category . | Donor . | No Donor . | Hazard Ratio . | 95% CI . |
| * Significant benefit in the donor group, (p < 0.05). | ||||
| ‡ Unpublished observations, Cornelissen J, van Putten W, Löwenberg B, on behalf of the HOVON/SAKK AML-study group | ||||
| Abbreviations: CI, confidence interval; EORTC-GIMEMA (EORTC; European Organization for Research and Treatment of Cancer, GIMEMA; Gruppo Italiano Malattie Ematologiche dell’Adulto); MRC 10 (MRC; Medical Research Council); HOVON/SAKK (HOVON; Dutch-Belgian Hemato-Oncology Cooperative Group, SAKK; Swiss Group for Clinical Cancer Research) | ||||
| EORTC-GIMEMA (6) | ||||
| Intermediate | 61 | 104 | 1.16 | (0.75–1.81) |
| Poor and very poor | 64 | 94 | 0.58* | (0.39–0.87) |
| MRC 10 (5) | ||||
| intermediate | 192 | 416 | 0.74* | (0.59–0.92) |
| poor | 48 | 121 | 0.88 | (0.61–1.28) |
| HOVON/SAKK‡ | ||||
| intermediate | 187 | 336 | 0.76* | (0.59–0.92) |
| poor | 120 | 194 | 0.65* | (0.49–0.85) |
| . | No. of Patients . | . | ||
|---|---|---|---|---|
| Study Group (ref), Cytogenetic Risk Category . | Donor . | No Donor . | Hazard Ratio . | 95% CI . |
| * Significant benefit in the donor group, (p < 0.05). | ||||
| ‡ Unpublished observations, Cornelissen J, van Putten W, Löwenberg B, on behalf of the HOVON/SAKK AML-study group | ||||
| Abbreviations: CI, confidence interval; EORTC-GIMEMA (EORTC; European Organization for Research and Treatment of Cancer, GIMEMA; Gruppo Italiano Malattie Ematologiche dell’Adulto); MRC 10 (MRC; Medical Research Council); HOVON/SAKK (HOVON; Dutch-Belgian Hemato-Oncology Cooperative Group, SAKK; Swiss Group for Clinical Cancer Research) | ||||
| EORTC-GIMEMA (6) | ||||
| Intermediate | 61 | 104 | 1.16 | (0.75–1.81) |
| Poor and very poor | 64 | 94 | 0.58* | (0.39–0.87) |
| MRC 10 (5) | ||||
| intermediate | 192 | 416 | 0.74* | (0.59–0.92) |
| poor | 48 | 121 | 0.88 | (0.61–1.28) |
| HOVON/SAKK‡ | ||||
| intermediate | 187 | 336 | 0.76* | (0.59–0.92) |
| poor | 120 | 194 | 0.65* | (0.49–0.85) |